No serious suspected adverse events (AEs) associated with the Covid-19 vaccine have been reported for children between five and 11 years old as at Dec 31, said the Health Sciences Authority (HSA).
It has received reports of non-serious AEs such as hives, dizziness, fever and shortness of breath in that age group, it added in a safety update on Wednesday (Jan 19).
Since the Covid-19 vaccination programme was rolled out to children aged five to 11 on Dec 27 last year, six non-serious reports have been logged for this age group.
This is equivalent to 0.03 per cent out of 20,327 administered doses.
For the age group of 12 to 18, the most commonly reported AEs are rash, hives, angioedema – which refers to the swelling of the eyelids, face and lips – as well as shortness of breath, palpitations, chest tightness or discomfort, fever, dizziness, light headedness and syncope, which refers to fainting and brief episode of loss of consciousness.
HSA received 1,170 AE reports associated with the use of mRNA vaccines in adolescents aged 12 to 18, out of 663,239 administered doses.
This makes up 0.18 per cent of doses administered.